High invasiveness of pneumococcal serotypes included in the new generation of conjugate vaccines

E. del Amo, P. Brotons, M. Monsonis, M. Triviño, M. Iñigo, L. Selva, R. Sa-Leão, C. Muñoz-Almagro

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The implementation of the seven-valent pneumococcal conjugate vaccine, PCV7, has resulted in significant changes in the pneumococcal population being carried and causing disease. We aimed to determine the invasive disease potential of serotypes causing invasive paediatric disease in the era of conjugate vaccines in Catalonia, Spain, and their potential coverage by the 13-valent pneumococcal conjugate vaccine, PCV13. As a secondary objective, we evaluated whether implementation of PCV7 had resulted in significant changes in the invasive disease potential of the most frequent serotypes circulating in the area. Two pneumococcal collections obtained from children admitted to the University Hospital Sant Joan de Déu (Barcelona, Spain) between 2007 and 2011 were compared: a first set of 159 invasive disease isolates, and a second set of 209 nasopharyngeal isolates recovered from healthy children admitted for minor surgery. The most common invasive serotypes were 1 (24.5%, n = 39), 19A (21.2%, n = 34), 5 (8.8%, n = 14), 7F (8.8%, n = 14) and 3 (5%, n = 8). The most common serotypes in carriage were 19A (10%, n = 21), 6C (9%, n = 19), 23B (8.1%, n = 17), 6A (7.6%, n = 16) and 19F (6.2%, n = 13). A significantly higher propensity to cause invasive disease was observed for serotypes 1, 3, 5, 7F and 19A, all of which are included in PCV13. After false-discovery-rate correction, the results were robust for serotypes 1, 5, 7F and 19A. Non-PCV13 serotypes had a low invasive disease potential. Our data reinforce the need for continuous surveillance and should encourage efforts to introduce universal vaccination with PCV13 in children in our region. Clinical Microbiology and Infection

Original languageEnglish
Pages (from-to)684-689
Number of pages6
JournalClinical Microbiology And Infection
Volume20
Issue number7
DOIs
Publication statusPublished - 2014

Fingerprint

Conjugate Vaccines
Spain
Minor Surgical Procedures
Pneumococcal Vaccines
Microbiology
Serogroup
Vaccination
Pediatrics
Infection
Population

Keywords

  • Carriage
  • Conjugate vaccines
  • Pneumococcal disease
  • Serotypes
  • Streptococcus pneumoniae

Cite this

del Amo, E., Brotons, P., Monsonis, M., Triviño, M., Iñigo, M., Selva, L., ... Muñoz-Almagro, C. (2014). High invasiveness of pneumococcal serotypes included in the new generation of conjugate vaccines. Clinical Microbiology And Infection, 20(7), 684-689. https://doi.org/10.1111/1469-0691.12422
del Amo, E. ; Brotons, P. ; Monsonis, M. ; Triviño, M. ; Iñigo, M. ; Selva, L. ; Sa-Leão, R. ; Muñoz-Almagro, C. / High invasiveness of pneumococcal serotypes included in the new generation of conjugate vaccines. In: Clinical Microbiology And Infection. 2014 ; Vol. 20, No. 7. pp. 684-689.
@article{e7fcc3272cd44557a36c1258436fab81,
title = "High invasiveness of pneumococcal serotypes included in the new generation of conjugate vaccines",
abstract = "The implementation of the seven-valent pneumococcal conjugate vaccine, PCV7, has resulted in significant changes in the pneumococcal population being carried and causing disease. We aimed to determine the invasive disease potential of serotypes causing invasive paediatric disease in the era of conjugate vaccines in Catalonia, Spain, and their potential coverage by the 13-valent pneumococcal conjugate vaccine, PCV13. As a secondary objective, we evaluated whether implementation of PCV7 had resulted in significant changes in the invasive disease potential of the most frequent serotypes circulating in the area. Two pneumococcal collections obtained from children admitted to the University Hospital Sant Joan de D{\'e}u (Barcelona, Spain) between 2007 and 2011 were compared: a first set of 159 invasive disease isolates, and a second set of 209 nasopharyngeal isolates recovered from healthy children admitted for minor surgery. The most common invasive serotypes were 1 (24.5{\%}, n = 39), 19A (21.2{\%}, n = 34), 5 (8.8{\%}, n = 14), 7F (8.8{\%}, n = 14) and 3 (5{\%}, n = 8). The most common serotypes in carriage were 19A (10{\%}, n = 21), 6C (9{\%}, n = 19), 23B (8.1{\%}, n = 17), 6A (7.6{\%}, n = 16) and 19F (6.2{\%}, n = 13). A significantly higher propensity to cause invasive disease was observed for serotypes 1, 3, 5, 7F and 19A, all of which are included in PCV13. After false-discovery-rate correction, the results were robust for serotypes 1, 5, 7F and 19A. Non-PCV13 serotypes had a low invasive disease potential. Our data reinforce the need for continuous surveillance and should encourage efforts to introduce universal vaccination with PCV13 in children in our region. Clinical Microbiology and Infection",
keywords = "Carriage, Conjugate vaccines, Pneumococcal disease, Serotypes, Streptococcus pneumoniae",
author = "{del Amo}, E. and P. Brotons and M. Monsonis and M. Trivi{\~n}o and M. I{\~n}igo and L. Selva and R. Sa-Le{\~a}o and C. Mu{\~n}oz-Almagro",
note = "WOS:000340199000024",
year = "2014",
doi = "10.1111/1469-0691.12422",
language = "English",
volume = "20",
pages = "684--689",
journal = "Clinical Microbiology And Infection",
issn = "1198-743X",
publisher = "Blackwell Publishing Ltd",
number = "7",

}

del Amo, E, Brotons, P, Monsonis, M, Triviño, M, Iñigo, M, Selva, L, Sa-Leão, R & Muñoz-Almagro, C 2014, 'High invasiveness of pneumococcal serotypes included in the new generation of conjugate vaccines', Clinical Microbiology And Infection, vol. 20, no. 7, pp. 684-689. https://doi.org/10.1111/1469-0691.12422

High invasiveness of pneumococcal serotypes included in the new generation of conjugate vaccines. / del Amo, E.; Brotons, P.; Monsonis, M.; Triviño, M.; Iñigo, M.; Selva, L.; Sa-Leão, R.; Muñoz-Almagro, C.

In: Clinical Microbiology And Infection, Vol. 20, No. 7, 2014, p. 684-689.

Research output: Contribution to journalArticle

TY - JOUR

T1 - High invasiveness of pneumococcal serotypes included in the new generation of conjugate vaccines

AU - del Amo, E.

AU - Brotons, P.

AU - Monsonis, M.

AU - Triviño, M.

AU - Iñigo, M.

AU - Selva, L.

AU - Sa-Leão, R.

AU - Muñoz-Almagro, C.

N1 - WOS:000340199000024

PY - 2014

Y1 - 2014

N2 - The implementation of the seven-valent pneumococcal conjugate vaccine, PCV7, has resulted in significant changes in the pneumococcal population being carried and causing disease. We aimed to determine the invasive disease potential of serotypes causing invasive paediatric disease in the era of conjugate vaccines in Catalonia, Spain, and their potential coverage by the 13-valent pneumococcal conjugate vaccine, PCV13. As a secondary objective, we evaluated whether implementation of PCV7 had resulted in significant changes in the invasive disease potential of the most frequent serotypes circulating in the area. Two pneumococcal collections obtained from children admitted to the University Hospital Sant Joan de Déu (Barcelona, Spain) between 2007 and 2011 were compared: a first set of 159 invasive disease isolates, and a second set of 209 nasopharyngeal isolates recovered from healthy children admitted for minor surgery. The most common invasive serotypes were 1 (24.5%, n = 39), 19A (21.2%, n = 34), 5 (8.8%, n = 14), 7F (8.8%, n = 14) and 3 (5%, n = 8). The most common serotypes in carriage were 19A (10%, n = 21), 6C (9%, n = 19), 23B (8.1%, n = 17), 6A (7.6%, n = 16) and 19F (6.2%, n = 13). A significantly higher propensity to cause invasive disease was observed for serotypes 1, 3, 5, 7F and 19A, all of which are included in PCV13. After false-discovery-rate correction, the results were robust for serotypes 1, 5, 7F and 19A. Non-PCV13 serotypes had a low invasive disease potential. Our data reinforce the need for continuous surveillance and should encourage efforts to introduce universal vaccination with PCV13 in children in our region. Clinical Microbiology and Infection

AB - The implementation of the seven-valent pneumococcal conjugate vaccine, PCV7, has resulted in significant changes in the pneumococcal population being carried and causing disease. We aimed to determine the invasive disease potential of serotypes causing invasive paediatric disease in the era of conjugate vaccines in Catalonia, Spain, and their potential coverage by the 13-valent pneumococcal conjugate vaccine, PCV13. As a secondary objective, we evaluated whether implementation of PCV7 had resulted in significant changes in the invasive disease potential of the most frequent serotypes circulating in the area. Two pneumococcal collections obtained from children admitted to the University Hospital Sant Joan de Déu (Barcelona, Spain) between 2007 and 2011 were compared: a first set of 159 invasive disease isolates, and a second set of 209 nasopharyngeal isolates recovered from healthy children admitted for minor surgery. The most common invasive serotypes were 1 (24.5%, n = 39), 19A (21.2%, n = 34), 5 (8.8%, n = 14), 7F (8.8%, n = 14) and 3 (5%, n = 8). The most common serotypes in carriage were 19A (10%, n = 21), 6C (9%, n = 19), 23B (8.1%, n = 17), 6A (7.6%, n = 16) and 19F (6.2%, n = 13). A significantly higher propensity to cause invasive disease was observed for serotypes 1, 3, 5, 7F and 19A, all of which are included in PCV13. After false-discovery-rate correction, the results were robust for serotypes 1, 5, 7F and 19A. Non-PCV13 serotypes had a low invasive disease potential. Our data reinforce the need for continuous surveillance and should encourage efforts to introduce universal vaccination with PCV13 in children in our region. Clinical Microbiology and Infection

KW - Carriage

KW - Conjugate vaccines

KW - Pneumococcal disease

KW - Serotypes

KW - Streptococcus pneumoniae

UR - http://www.scopus.com/inward/record.url?scp=84905057704&partnerID=8YFLogxK

U2 - 10.1111/1469-0691.12422

DO - 10.1111/1469-0691.12422

M3 - Article

VL - 20

SP - 684

EP - 689

JO - Clinical Microbiology And Infection

JF - Clinical Microbiology And Infection

SN - 1198-743X

IS - 7

ER -